Please assess the completion status of the following clinical trial:

Trial Title: An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Enrollment in Protocol GIPF 002 Part B or GIPF-004~* Completion of the End of Treatment Visit in Protocol GIPF-002 Part B or the Study Completion Visit in GIPF-004~* Able to understand and sign a written informed consent form and comply with the requirements of the study~Exclusion criteria:~* pregnancy or lactation~* lack of adherence to either GIPF-002 or GIPF-004 study protocols and treatment regimens~* if Principal Investigator deems patient is unsuitable for study

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).